Introduction: We evaluated the frequencies of various glycemic markers derived from continuous glucose monitoring in Japanese children and adolescents with type 1 diabetes and assessed the significance of hypoglycemia duration. Methods: We enrolled 85 children and adolescents (36 boys and 49 girls) with type 1 diabetes who used FreeStyle® Libre in the present study. Frequencies of blood glucose levels as time within target range (TIR; 70–180 mg/dL), time below target range (TBR; <70 mg/dL), time below extreme hypoglycemia range (TBER; <54 mg/dL), and time above range (TAR; >180 mg/dL) were assessed during a 3-month study period. Furthermore, we evaluated the intraday frequencies of TBR and TBER. Results: The mean frequencies of TIR, TBR, and TAR were 52.7 ± 11.3%, 10.8 ± 5.4%, and 36.5 ± 10.8%, respectively, whereas the mean frequency of TBER was 1.1 ± 0.9% (0–3.0%); there was no clinical episode of severe hypoglycemia. The mean frequency of TBR was significantly greater in 0–6 h (16.9 ± 5.2%) than in 6–12 h (7.8 ± 2.9%) and 18–24 h (6.8 ± 4.8%; p < 0.01) time zones, respectively. Discussion/Conclusion: We found similar TIR and comparatively higher TBR frequencies, particularly during sleep, than those that were previously reported. Possible reasons for the higher frequency of TBR include differences in the quality of insulin treatment and diabetes care between the present study and the European studies. The utilization of advanced technologies, such as a predictive low-glucose suspend-function pump or closed-loop therapy, can reduce the frequency of TBR, with a consequent increase in TIR frequency and comprehensive improvement in glycemic control.

1.
Battelino
T
,
Danne
T
,
Bergenstal
RM
,
Amiel
SA
,
Beck
R
,
Biester
T
, et al
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range
.
Diabetes Care
.
2019 Jun
;
42
(
8
):
1593
603
.
2.
Ly
TT
,
Maahs
DM
,
Rewers
A
,
Dunger
D
,
Oduwole
A
,
Jones
TW
.
ISPAD clinical practice consensus guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes
.
Pediatr Diabetes
.
2018 Oct
;
15 Suppl 20
(
Suppl 27
):
180
92
.
3.
Skrivarhaug
T
,
Bangstad
HJ
,
Stene
LC
,
Sandvik
L
,
Hanssen
KF
,
Joner
G
.
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
.
Diabetologia
.
2006 Feb
;
49
(
2
):
298
305
.
4.
Patterson
CC
,
Dahlquist
G
,
Harjutsalo
V
,
Joner
G
,
Feltbower
RG
,
Svensson
J
, et al
Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989
.
Diabetologia
.
2007 Dec
;
50
(
12
):
2439
42
.
5.
DiMeglio
LA
,
Acerini
CL
,
Codner
E
,
Craig
ME
,
Hofer
SE
,
Pillay
K
, et al
ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
.
Pediatr Diabetes
.
2018 Oct
;
19
(
Suppl 27
):
105
14
.
6.
Bergenstal
RM
,
Garg
S
,
Weinzimer
SA
,
Buckingham
BA
,
Bode
BW
,
Tamborlane
WV
, et al
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
.
JAMA
.
2016 Oct
;
316
(
13
):
1407
8
.
7.
Danne
T
,
Nimri
R
,
Battelino
T
,
Bergenstal
RM
,
Close
KL
,
Devries
JH
, et al
International consensus on use of continuous glucose monitoring
.
Diabetes Care
.
2017 Dec
;
40
(
12
):
1631
40
.
8.
Campbell
F
,
Kordonouri
O
,
Murphy
N
,
Stewart
C
.
FreeStyle Libre use for self-management of diabetes in children and adolescents
.
110-LB, Program of 77th American diabetes association scientific sessions
;
2017 Jun
;
110-LB
(
Abstract
),
San Diego, California, USA
.
9.
Dunn
TC
,
Xu
Y
,
Hayter
G
,
Ajjan
RA
.
Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests
.
Diabetes Res Clin Pract
.
2018 Mar
;
137
:
37
46
.
10.
Edge
J
,
Acerini
C
,
Campbell
F
,
Hamilton-Shield
J
,
Moudiotis
C
,
Rahman
S
, et al
An alternative sensor-based method for glucose monitoring in children and young people with diabetes
.
Arch Dis Child
.
2017 Jan
;
102
(
6
):
543
9
.
11.
Gaudieri
PA
,
Chen
R
,
Greer
TF
,
Holmes
CS
.
Cognitive function in children with type 1 diabetes: a meta-analysis
.
Diabetes Care
.
2008 Sep
.
31
(
9
):
1892
7
.
12.
Naguib
JM
,
Kulinskaya
E
,
Lomax
CL
,
Garralda
ME
.
Neuro-cognitive performance in children with type 1 diabetes: a meta-analysis
.
J Pediatr Psychol
.
2009 Apr
;
34
(
3
):
271
82
.
13.
Pell
GS
,
Lin
A
,
Wellard
RM
,
Werther
GA
,
Cameron
FJ
,
Finch
SJ
, et al
Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes
.
Diabetes Care
.
2012 Jan
;
35
(
3
):
513
9
.
14.
Aye
T
,
Reiss
AL
,
Kesler
S
,
Hoang
S
,
Drobny
J
,
Park
Y
, et al
The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children
.
Diabetes Care
.
2011 Jul
;
34
(
7
):
1458
62
.
15.
Heller
SR
,
Cryer
PE
.
Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans
.
Diabetes
.
1991 Feb
;
40
(
2
):
223
6
.
16.
Dagogo-Jack
SE
,
Craft
S
,
Cryer
PE
.
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia
.
J Clin Invest
.
1993 Mar
;
91
(
3
):
819
28
.
17.
Gold
AE
,
MacLeod
KM
,
Frier
BM
.
Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia
.
Diabetes Care
.
1994 Jul
;
17
(
7
):
697
703
.
18.
Beregszàszi
M
,
Tubiana-Rufi
N
,
Benali
K
,
Noël
M
,
Bloch
J
,
Czernichow
P
.
Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors
.
J Pediatr
.
1997 Dec
;
131
(
1 Pt 1
):
27
33
.
19.
Matyka
KA
,
Wigg
L
,
Pramming
S
,
Stores
G
,
Dunger
DB
.
Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes
.
Arch Dis Child
.
1999 Aug
;
81
(
2
):
138
42
.
20.
Kaufman
FR
,
Austin
J
,
Neinstein
A
,
Jeng
L
,
Halvorson
M
,
Devoe
DJ
, et al
Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes
.
J Pediatr
.
2002 Nov
;
141
(
5
):
625
30
.
21.
Wilson
DM
,
Calhoun
PM
,
Maahs
DM
,
Chase
HP
,
Messer
L
,
Buckingham
BA
, et al
Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes
.
Diabetes Technol Ther
.
2015 Jun
;
17
(
6
):
385
91
.
22.
Buckingham
BA
,
Cameron
F
,
Calhoun
P
,
Maahs
DM
,
Wilson
DM
,
Chase
HP
, et al
Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia
.
Diabetes Technol Ther
.
2013 Aug
;
15
(
8
):
622
7
.
23.
Porter
PA
,
Keating
B
,
Byrne
G
,
Jones
TW
.
Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus
.
J Pediatr
.
1997 Mar
;
130
(
3
):
366
72
.
24.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
.
Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes
.
Diabetes Care
.
2010 May
;
33
(
5
):
1004
8
.
25.
Buckingham
B
,
Block
J
,
Burdick
J
,
Kalajian
A
,
Kollman
C
,
Choy
M
, et al
Response to nocturnal alarms using a real-time glucose sensor
.
Diabetes Technol Ther
.
2005 Jan
;
7
(
3
):
440
7
.
26.
Bolinder
J
,
Antuna
R
,
Geelhoed-Duijvestijn
P
,
Kröger
J
,
Weitgasser
R
.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
.
Lancet
.
2016 Nov
;
388
(
10057
):
2254
63
.
27.
Reddy
M
,
Jugnee
N
,
El Laboudi
A
,
Spanudakis
E
,
Anantharaja
S
,
Oliver
N
.
A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia
.
Diabet Med
.
2018 Apr
;
35
(
4
):
483
90
.
28.
Edelman
SV
,
Argento
NB
,
Pettus
J
,
Hirsch
IB
.
Clinical implications of real-time and intermittently scanned continuous glucose monitoring
.
Diabetes Care
.
2018 Nov
;
41
(
11
):
2265
74
.
29.
Danne
T
,
Kordonouri
O
,
Holder
M
,
Haberland
H
,
Golembowski
S
,
Remus
K
, et al
Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy
.
Diabetes Technol Ther
.
2011 Nov
;
13
(
11
):
1129
34
.
30.
Beato-Víbora
PI
,
Quirós-López
C
,
Lázaro-Martín
L
,
Martín-Frías
M
,
Barrio-Castellanos
R
,
Gil-Poch
E
, et al
Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes
.
Diabetes Technology Ther
.
2018 Nov
;
20
(
11
):
738
43
.
31.
Messer
LH
,
Forlenza
GP
,
Sherr
JL
,
Wadwa
RP
,
Buckingham
BA
,
Weinzimer
SA
, et al
Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the miniMed 670G system
.
Diabetes Care
.
2018 Apr
;
41
(
4
):
789
96
.
32.
Bergenstal
RM
,
Garg
S
,
Weinzimer
SA
,
Buckingham
BA
,
Bode
BW
,
Tamborlane
WV
, et al
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
.
JAMA
.
2016 Oct
;
316
(
13
):
1407
8
.
33.
Miles
HL
,
Acerini
CL
.
Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus
.
Paediatr Drugs
.
2008 Jun
;
10
(
3
):
163
76
.
34.
Urakami
T
,
Mine
Y
,
Aoki
M
,
Okuno
M
,
Suzuki
J
.
A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
.
Endocr J
.
2017 Feb
;
64
(
2
):
133
40
.
35.
Szadkowska
A
,
Gawrecki
A
,
Michalak
A
,
Zozulińska-Ziółkiewicz
D
,
Fendler
W
,
Młynarski
W
.
Flash glucose measurements in children with type 1 diabetes in real-life settings: to trust or not to trust?
Diabetes Technology Ther
.
2018 Jan
;
20
(
1
):
17
24
.
36.
Michalak
A
,
Pagacz
K
,
Młynarski
W
,
Szadkowska
A
,
Fendler
W
.
Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes
.
Pediatr Diabetes
.
2019 Aug
;
20
(
5
):
604
12
.
37.
Boucher
SE
,
Gray
AR
,
de Bock
M
,
Wiltshire
EJ
,
Galland
BC
,
Tomlinson
PA
, et al
Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol
.
BMC Endocr Disord
.
2019 May
;
19
(
1
):
50
.
38.
Piona
C
,
Dovc
K
,
Mutlu
GY
,
Grad
K
,
Gregorc
P
,
Battelino
T
, et al
Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: the free-summer study
.
Pediatr Diabetes
.
2018 Nov
;
19
(
7
):
1285
93
.
39.
Evans
M
,
Welsh
Z
,
Ells
S
,
Seibold
A
.
The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies
.
Diabetes Ther
.
2020
;
11
(
1
):
83
95
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.